急性重型病毒性肝炎患者CAR、CLR、SIRI变化及其对不良预后的评估效能OA
Study on the changing trend of CAR,CLR and SIRI levels and the efficacy of evaluating poor prognosis in patients with acute severe viral hepatitis
目的 探究急性重型病毒性肝炎患者C反应蛋白/白蛋白比值(CAR)、C反应蛋白/淋巴细胞比值(CLR)、全身炎性反应指数(SIRI)的变化及其对不良预后的评估效能.方法 前瞻性选取2023年6月—2025年3月新疆医科大学第一附属医院感染病重症科诊治的急性重型病毒性肝炎患者115例作为研究对象,根据治疗后3个月内预后情况将患者分为预后良好组(n=81)和预后不良组(n=34).Spearman法分析差异性指标与急性重型病毒性肝炎患者短期预后不良的相关性;多因素Logistic回归分析急性重型病毒性肝炎患者短期预后不良的影响因素;受试者工作特征(ROC)曲线分析CAR、CLR、SIRI对急性重型病毒性肝炎患者短期预后不良的预测效能.结果 预后不良组肝性脑病比例、ALT、CRP、CAR、CLR、SIRI高于预后良好组,PTA、Alb低于预后良好组(x2/P=4.338/0.037,t/P=6.137/<0.001、6.001/<0.001、5.998/<0.001、6.990/<0.001、9.023/<0.001、6.093/<0.001、8.193/<0.001);Spearman 相关性分析显示,肝性脑病、ALT、CRP、CAR、CLR、SIRI与急性重型病毒性肝炎患者短期预后不良呈正相关(rs/P=0.194/0.038、0.294/0.003、0.492/<0.001、0.439/<0.001、0.484/<0.001、0.440/<0.001),PTA、Alb 与急性重型病毒性肝炎患者短期预后不良呈负相关(rs/P=-0.299/0.001、-0.366/<0.001);CAR、CLR、SIRI高是急性重型病毒性肝炎患者短期预后不良的独立危险因素[OR(95%CI)=2.788(1.036~5.756)、4.413(1.665~7.701)、3.185(2.757~5.790)];CAR、CLR、SIRI单独及三者联合预测急性重型病毒性肝炎患者短期预后不良的曲线下面积(AUC)分别为0.777、0.806、0.779、0.948,三者联合预测的效能高于各指标单独预测(Z/P=5.321/<0.001、5.013/<0.001、5.320/<0.001).结论 急性重型病毒性肝炎患者CAR、CLR、SIRI升高与短期预后不良密切相关,密切监测3项指标可有效评估急性重型病毒性肝炎患者的临床转归.
Objective To investigate the trends in levels of C-reactive protein/albumin ratio(CAR),C-reactive pro-tein/lymphocyte ratio(CLR),and systemic inflammatory response index(SIRI)and their efficacy in assessing adverse out-comes in patients with acute severe viral hepatitis.Methods This study is a prospective observational study.A total of 115 patients with acute severe viral hepatitis diagnosed and treated in the Department of Critical Infectious Diseases,the First Affil-iated Hospital of Xinjiang Medical University from June 2023 to March 2025 were selected as the study subjects.Based on their prognosis within 3 months after treatment,they were divided into a good prognosis group(n=81)and a poor prognosis group(n=34).Clinical data and the expression levels of neutrophil-to-lymphocyte ratio(NLR),SIRI,C-reactive protein(CRP),albumin(ALB),CAR,and CLR were measured and compared between the two groups.Spearman correlation analysis and multivariate logistic regression analysis were used to identify risk factors for short-term poor prognosis in patients with acute severe viral hepatitis,and the combined assessment efficacy of these risk factors was evaluated.Results The proportion of patients with hepatic encephalopathy,as well as the levels of ALT,CRP,CAR,CLR,and SIRI,were significantly higher in the poor prognosis group compared to the good prognosis group.In contrast,prothrombin activity(PTA)and ALB levels were significantly lower(x2/t/P=4.338/0.037,6.137/<0.001,6.093/<0.001,6.001/<0.001,8.193/<0.001,5.998/<0.001,6.990/<0.001,9.023/<0.001).Spearman correlation analysis revealed that the presence of hepatic encephalopathy,ALT,CRP,CAR,CLR,and SIRI levels were positively correlated with short-term poor prognosis,whereas PTA and ALB levels were negatively correlated(rs/P=0.194/0.038,0.294/0.003,-0.299/0.001,0.492/<0.001,-0.366/<0.001,0.439/<0.001,0.484/<0.001,0.440/<0.001).Ele-vated CAR,CLR,and SIRI were identified as significant independent risk factors for short-term poor prognosis[OR(95%CI)=2.788(1.036-5.756),4.413(1.665-7.701),3.185(2.757-5.790)].The areas under the curve(AUC)for CAR,CLR,SIRI,and their combination in predicting short-term poor prognosis were 0.777,0.806,0.779,and 0.948,respectively.The combined pre-dictive model demonstrated the highest efficacy(Z=5.321,5.013,5.320;all P<0.001).Conclusion Higher levels of CAR,CLR,and SIRI in patients with acute severe viral hepatitis are closely associated with short-term poor prognosis.Close moni-toring of these indicators can effectively assess the clinical outcomes of these patients and holds value in guiding clinical treat-ment.
热依汗·司马义;姚磊;郑丽娇;孙晓;潘金良;刘浩
830054 乌鲁木齐,新疆医科大学第一附属医院感染病重症科830054 乌鲁木齐,新疆医科大学第一附属医院感染病重症科830054 乌鲁木齐,新疆医科大学第一附属医院感染病重症科830054 乌鲁木齐,新疆医科大学第一附属医院感染病重症科830054 乌鲁木齐,新疆医科大学第一附属医院感染病重症科830054 乌鲁木齐,新疆医科大学第一附属医院感染病肝病中心
医药卫生
急性重型病毒性肝炎C反应蛋白/白蛋白比值C反应蛋白/淋巴细胞比值全身炎性反应指数预后
Acute severe viral hepatitisC-reactive protein/albumin ratioC-reactive protein/lymphocyte ratioSys-temic inflammatory response indexPrognosis
《疑难病杂志》 2026 (5)
557-561,5
新疆维吾尔自治区自然科学基金资助项目(2023D01C352) Project Funded by the Natural Science Foundation of Xinjiang Uygur Autonomous Region(2023D01C352)
评论